Table 3.
Variable | Multivariate analysis | |
---|---|---|
| ||
HR (95% CI) | P value | |
Sex, male versus female | 0.194 (0.869-1.063) | 0.440 |
Age, < 50 versus ≥ 50 years | 0.238 (0.832-1.070) | 0.365 |
Tumor sizes, ≤ 3 versus > 3 cm | 0.244 (0.835-1.079) | 0.421 |
TPSA, ≤ 80 µg/ml versus > 80 µg/ml | 0.247 (0.886-1.133) | 0.966 |
SCC, ≤ 1.5 µg/ml versus > 1.5 µg/ml | 0.476 (0.981-1.457) | 0.076 |
NSE, ≤ 15.2 µg/ml versus > 15.2 µg/ml | 0.22 (0.711-0.931) | 0.003* |
CEA, ≤ 5 µg/ml versus > 5 µg/ml | 0.236 (1.073-1.309) | 0.001* |
Cyfra 21-1, ≤ 3.3 µg/ml versus > 3.3 µg/ml | 0.217 (0.873-1.090) | 0.659 |
EGFR, wild versus mutation | 0.192 (0.896-1.088) | 0.795 |
Histologic style | 0.068 (0.992-1.060) | 0.140 |
Lymph metastasis, present versus absent | 0.407 (1.868-2.275) | < 0.001* |
Smoking, never versus former or current | 0.23 (0.996-1.226) | 0.057 |
CAMKII, low versus high | 0.135 (1.000-1.135) | 0.049* |
Significantly different.